by TJ Sponsel II
January 31, 2020

Cannabis companies have traditionally been unable to claim R&D credits due to 26 U.S. Code § 280E, which prohibits any business engaged in trafficking Schedule I or II substances from claiming any federal tax deductions or credits.

<Read More
Filter Type
Filter By Category